Literature DB >> 11752862

Testicular microlithiasis: is it a benign condition with malignant potential?

U Otite1, J A Webb, R T Oliver, D F Badenoch, V H Nargund.   

Abstract

OBJECTIVE: To review the findings of testicular ultrasonography (US) in patients referred for testicular symptoms including pain, swelling and infertility, and to determine the prevalence of testicular microlithiasis (TM) and ist relevance to the development of testicular cancer.
METHODS: Records of 3,026 patients referred for testicular US between 1994 and 1999 were evaluated. The indications for testicular US diagnosis, management and relevant histological details were obtained from medical records. Patients with TM had an annual sonographic follow-up unless they had testicular cancer, in which case follow-up repeat US with clinical reviews was more frequent.
RESULTS: TM was found in 54 patients (1.77%; median age 34 years, range 12-83 years). The median follow-up was 36 months (range 12-18 months). Sixteen of these patients had testicular malignancy (30%). The remaining 38 patients had hydrocele and epididymal cysts (14), varicocele (7), epididymitis (2) and small testes (8), with 14 patients having no other pathology. One patient with a small testis developed a seminoma while under surveillance. Another patient with metastatic embryonal-cell carcinoma at initial diagnosis was found to have a seminoma 4 years following chemotherapy. The relative risk of testicular tumours in the presence of TM was 13.2 (confidence interval 8.3-21.5).
CONCLUSION: TM can no longer be regarded simply as a benign condition because of its association with testicular malignancy. In our series, 2 patients (5.2%) developed interval testicular cancers during follow-up US. There is no convincing evidence to suggest that TM might be premalignant. In rare instances of radiologically indeterminate cases, biopsy of the testis may be necessary.

Entities:  

Mesh:

Year:  2001        PMID: 11752862     DOI: 10.1159/000049832

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  8 in total

1.  Testicular microlithiasis an ultrasound dilemma: survey of opinions regarding significance and management amongst UK ultrasound practitioners.

Authors:  D Shetty; A G Bailey; S J Freeman
Journal:  Br J Radiol       Date:  2013-12-05       Impact factor: 3.039

2.  Testicular microlithiasis: is there a need for surveillance in the absence of other risk factors?

Authors:  Jonathan Richenberg; Nick Brejt
Journal:  Eur Radiol       Date:  2012-06-19       Impact factor: 5.315

3.  Testicular calcification and microlithiasis: association with primary intra-testicular malignancy in 3,477 patients.

Authors:  Fiona N A C Miller; Shantini Rosairo; Jane L Clarke; Seshadri Sriprasad; Gordon H Muir; Paul S Sidhu
Journal:  Eur Radiol       Date:  2006-05-18       Impact factor: 5.315

Review 4.  Testicular microlithiasis: clinical significance and review of the literature.

Authors:  Bohyun Kim; Thomas C Winter; Jeong-ah Ryu
Journal:  Eur Radiol       Date:  2003-10-03       Impact factor: 5.315

5.  Testicular microlithiasis: prevalence and clinical significance in a population referred for scrotal ultrasonography.

Authors:  Woo Seoung Yee; Young Soo Kim; Se Jung Kim; Jung Bo Choi; Sun Il Kim; Hyun Soo Ahn
Journal:  Korean J Urol       Date:  2011-03-18

6.  Association between testicular microlithiasis and primary malignancy of the testis: our experience and review of the literature.

Authors:  G C Parenti; S Zago; M Lusa; P Campioni; P Mannella
Journal:  Radiol Med       Date:  2007-06-11       Impact factor: 6.313

7.  Increased prevalence of testicular microlithiasis in men with familial testicular cancer and their relatives.

Authors:  L A Korde; A Premkumar; C Mueller; P Rosenberg; C Soho; G Bratslavsky; M H Greene
Journal:  Br J Cancer       Date:  2008-10-07       Impact factor: 7.640

8.  Testicular microlithiasis and testicular tumor: a review of the literature.

Authors:  Louis Leblanc; François Lagrange; Pierre Lecoanet; Baptiste Marçon; Pascal Eschwege; Jacques Hubert
Journal:  Basic Clin Androl       Date:  2018-07-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.